cyclophosphamide , an immunosuppressive agent , was administered as an additional mode of therapy to 30 patients with idiopathic thrombocytopenic purpura ( itp ) refractory to conventional management .
C0010583
cyclophosphamide
C0398650
idiopathic thrombocytopenic purpura